ロード中...
A134 ANTI-IL-12/23P40 ANTIBODIES FOR MAINTENANCE OF REMISSION IN CROHN’S DISEASE
BACKGROUND: Ustekinumab (CNTO 1275) is a monoclonal antibody that targets the standard p40 subunit of cytokines interleukin-12 and interleukin-23 (IL-12/23p40), which are involved in the pathogenesis of Crohn’s disease. AIMS: To assess the efficacy and safety of anti-IL-12/23p40 antibodies for maint...
保存先:
| 出版年: | J Can Assoc Gastroenterol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6508301/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy009.134 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|